Delivery Order SPE2DB22D1017-SPE2DB24FF3VK

Award Date 3/6/24
Potential Completion Date 3/7/24
Potential Value $6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of $5,225.64 worth of DOVATO 50-300 MG TABLET 30S pharmaceutical products. This delivery order has a completion date of March 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which is not set aside. Amerisourcebergen Drug Corp also holds an indefinite...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $27,934.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DOVATO 50-300 MG TABLET 30S, a pharmaceutical product. This delivery order contract has a completion date of February 29, 2024 and was awarded on February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which is not designated as a set-aside. The company also...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply DOVATO 50-300 MG TABLET 30S, a specialty pharmaceutical product, for a total ceiling value of $90,528.59. The award, which has a period of performance through March 20, 2024, was made on March 19, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of DOVATO 50-300 MG TABLET 30S. The total potential value of this award is $1,766.66, with a completion date of February 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which is not associated with any set-aside programs. This award falls under...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of DOVATO 50-300 MG TABLET 30S. The contract has a potential value of $24,636.22 and a completion date of February 5, 2024. This order is placed under an existing indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to deliver...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide DOVATO 50-300 MG tablets. The contract has a potential value of $6,626.28 and a completion date of January 31, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DOVATO 50-300 MG TABLET 30S, a pharmaceutical product, with a potential value of $5,186.67. The award has a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,610.82 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product, with a completion date of February 2, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of...
This is a $16,059.74 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product, with a period of performance through February 10, 2025. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Department of Defense's Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, for the supply of DOVATO 50-300 MG TABLET 30S. This $7,191.50 award has a completion date of February 7, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) valued up to...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF3VK
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical company Amerisourcebergen Corporation, to provide DOVATO 50-300 MG TABLET 30S. The $6,024.49 contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and has also received a separate indefinite delivery contract (IDC) from DLA valued up to $999,999,999.00 through December 2025 to deliver a wide range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. This contract is not designated as a set-aside.

Generated 6/5/24, 9:13 AM